Abstract Obesity is a major health concern worldwide, and its prevalence continues to increase in several countries
Primary evidence is supplemented by authoritative sources, including FDA.gov, NIH.gov, Mayo Clinic, and Cleveland Clinic, due to the limited number of recent peer-reviewed publications on this specific query
Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and Wegovy, as well as tirzepatide injections Zepbound and Mounjaro from competitor Eli Lilly
BPC-157 is a synthetic 15-amino acid peptide
Gallbladder disease Cholelithiasis and cholecystitis have been reported, consistent with rapid weight loss generally
Our team handles everything related to insurance verification and prior authorization, including submissions and follow-ups with your insurance provider